(Q53766889)

19 May 2018

title

MiRNA-221-3p desensitizes pancreatic cancer cells to 5-fluorouracil by targeting RB1. (English)

1 reference

19 May 2018

1 reference

1 reference

Lijun Zhao

1

1 reference

19 May 2018

Dongling Zou

2

1 reference

19 May 2018

Xueju Wei

3

1 reference

19 May 2018

Lanlan Wang

4

1 reference

19 May 2018

Yuanyuan Zhang

5

1 reference

19 May 2018

Siqi Liu

6

1 reference

19 May 2018

Yanmin Si

7

1 reference

19 May 2018

Hualu Zhao

8

1 reference

19 May 2018

Fang Wang

9

1 reference

19 May 2018

Jia Yu

10

1 reference

19 May 2018

Yanni Ma

11

1 reference

19 May 2018

Guotao Sun

12

1 reference

19 May 2018

publication date

10 October 2016

1 reference

19 May 2018

published in

Tumor Biology

1 reference

19 May 2018

https://scigraph.springernature.com/pub.10.1007/s13277-016-5445-8

exact match

0 references

cites work

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

Hyperglycemia as a mechanism of pancreatic cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

Overcoming drug resistance in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

The evolution of gene regulation by transcription factors and microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

MicroRNA-466l upregulates IL-10 expression in TLR-triggered macrophages by antagonizing RNA-binding protein tristetraprolin-mediated IL-10 mRNA degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

Small RNAs with imperfect match to endogenous mRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

MicroRNA regulation of core apoptosis pathways in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

Analysis of miR-221 and p27 expression in human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

Expression of microRNAs in patients with pancreatic cancer and its prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT)-Phenotypic Cells: Are They Cousins or Twins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

Pancreatic cancer: understanding and overcoming chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

Epithelial-mesenchymal transition in pancreatic cancer: Is it a clinically significant factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

Non-coding RNAs take centre stage in epithelial-to-mesenchymal transition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

MicroRNA expression and function in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

miRBase: annotating high confidence microRNAs using deep sequencing data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

Tumor suppressor miR-145 reverses drug resistance by directly targeting DNA damage-related gene RAD18 in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

MicroRNA dysregulation in uveal melanoma: a new player enters the game

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

Control of metastatic progression by microRNA regulatory networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

The microRNA networks of TGFβ signaling in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

Extensive modulation of a set of microRNAs in primary glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

p27Kip1 modulates cell migration through the regulation of RhoA activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

MicroRNAs and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

Role of microRNAs in vascular diseases, inflammation, and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

The role of microRNAs in normal and malignant hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

miR-221/222 targets adiponectin receptor 1 to promote the epithelial-to-mesenchymal transition in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

Molecular requirements for epithelial-mesenchymal transition during tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

Retinoblastoma: Clues to Human Oncogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5445-8

MicroRNAs in cancer treatment and prognosis.

21 January 2018

1 reference

12 December 2020

Cancer of the pancreas: are we making progress? A review of studies in the US Oncology Research Network

1 reference

12 December 2020

miR-221/222 promote malignant progression of glioma through activation of the Akt pathway.

1 reference

12 December 2020

Co-suppression of miR-221/222 cluster suppresses human glioma cell growth by targeting p27kip1 in vitro and in vivo

1 reference

12 December 2020

The promise of microRNA replacement therapy

1 reference

12 December 2020

Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells.

1 reference

12 December 2020

MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer

1 reference

12 December 2020

TRPS1 targeting by miR-221/222 promotes the epithelial-to-mesenchymal transition in breast cancer

1 reference

12 December 2020

Differential regulation of E2F and Sp1-mediated transcription by G1 cyclins.

1 reference

12 December 2020

Emerging targets in pancreatic cancer: epithelial-mesenchymal transition and cancer stem cells

1 reference

12 December 2020

10.1007/S13277-016-5445-8

Identifiers

DOI

1 reference

19 May 2018

PubMed ID

27726102

1 reference

19 May 2018